Join
Live feed
·
INSIDERFilingvia Quantisnow
Biodesix Inc. logo

Chief Commercial Officer O'Kane Kieran converted options into 1,489 shares and sold $198 worth of shares (476 units at $0.42), increasing direct ownership by 0.73% to 140,065 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BDSX (Biodesix Inc.) and more on Quantisnow.